GB1380247A - Anaesthetic compositions - Google Patents

Anaesthetic compositions

Info

Publication number
GB1380247A
GB1380247A GB6006970A GB6006970A GB1380247A GB 1380247 A GB1380247 A GB 1380247A GB 6006970 A GB6006970 A GB 6006970A GB 6006970 A GB6006970 A GB 6006970A GB 1380247 A GB1380247 A GB 1380247A
Authority
GB
United Kingdom
Prior art keywords
pregnane
dione
solution
recovered
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6006970A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB6006970A priority Critical patent/GB1380247A/en
Priority to CA130,269A priority patent/CA975682A/en
Priority to NL7117309A priority patent/NL7117309A/xx
Priority to BE776790A priority patent/BE776790A/xx
Priority to DE19712162591 priority patent/DE2162591A1/de
Priority to AU36963/71A priority patent/AU473308B2/en
Priority to FR7145230A priority patent/FR2118122B1/fr
Priority to IE1597/71A priority patent/IE36854B1/xx
Priority to ZA718467A priority patent/ZA718467B/xx
Priority to US307851A priority patent/US3900561A/en
Publication of GB1380247A publication Critical patent/GB1380247A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Steroid Compounds (AREA)
GB6006970A 1970-12-17 1970-12-17 Anaesthetic compositions Expired GB1380247A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB6006970A GB1380247A (en) 1970-12-17 1970-12-17 Anaesthetic compositions
CA130,269A CA975682A (en) 1970-12-17 1971-12-16 Anaesthetic compositions containing an anaesthetic steroid
NL7117309A NL7117309A (enExample) 1970-12-17 1971-12-16
BE776790A BE776790A (fr) 1970-12-17 1971-12-16 Compositions anesthesiques contenant des steroides anesthesiques solubles dans l'eau
DE19712162591 DE2162591A1 (de) 1970-12-17 1971-12-16 Anästhetische Zusammensetzungen
AU36963/71A AU473308B2 (en) 1970-12-17 1971-12-16 Steroid anaesthetic compositions
FR7145230A FR2118122B1 (enExample) 1970-12-17 1971-12-16
IE1597/71A IE36854B1 (en) 1970-12-17 1971-12-16 Anaesthetic compositions
ZA718467A ZA718467B (en) 1970-12-17 1971-12-17 Improvements in or relating to anaesthetic compositions
US307851A US3900561A (en) 1970-12-17 1972-11-20 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6006970A GB1380247A (en) 1970-12-17 1970-12-17 Anaesthetic compositions

Publications (1)

Publication Number Publication Date
GB1380247A true GB1380247A (en) 1975-01-08

Family

ID=10484953

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6006970A Expired GB1380247A (en) 1970-12-17 1970-12-17 Anaesthetic compositions

Country Status (9)

Country Link
AU (1) AU473308B2 (enExample)
BE (1) BE776790A (enExample)
CA (1) CA975682A (enExample)
DE (1) DE2162591A1 (enExample)
FR (1) FR2118122B1 (enExample)
GB (1) GB1380247A (enExample)
IE (1) IE36854B1 (enExample)
NL (1) NL7117309A (enExample)
ZA (1) ZA718467B (enExample)

Also Published As

Publication number Publication date
CA975682A (en) 1975-10-07
AU473308B2 (en) 1976-06-17
FR2118122B1 (enExample) 1975-12-26
DE2162591A1 (de) 1972-07-06
IE36854B1 (en) 1977-03-16
IE36854L (en) 1972-06-17
NL7117309A (enExample) 1972-06-20
FR2118122A1 (enExample) 1972-07-28
ZA718467B (en) 1973-08-29
AU3696371A (en) 1973-06-21
BE776790A (fr) 1972-06-16

Similar Documents

Publication Publication Date Title
NL277685A (nl) Werkwijze voor de gelijktijdige winning van zuiver ammoniumsulfaat en zuvere lactamen uit omzettingsmengsels val alicyclische ketoximen
GB1380247A (en) Anaesthetic compositions
BE816373A (fr) Procede de traitement d'esters bruts
CH377338A (fr) Procédé de préparation de stéroïdes de la série de l'androstane
US2867633A (en) 11-oxygenated-6-methyl-17alpha-hydroxy-4-pregnene-3, 20-diones
ES423694A1 (es) Un procedimiento para la preparacion de nuevos compuestos n-nitroso.
ES408023A1 (es) Un procedimiento para la preparacion de nuevos derivados decefalesperina y penicilina.
GB1068099A (en) Novel pharmacologically active steroid compounds of the pregnane series, process fortheir preparation, and pharmaceutical compositions containing them
US3019243A (en) 11beta-hydroxy-5beta-pregnane-3, 20-dione bisoximes and the 11alpha-lower-alkyl derivatives thereof
US2897198A (en) 11alpha-alkene-11beta-hydroxy-5beta-pregnanes
US2808415A (en) Delta4, 8(9)-3, 20-diketo-11, 17-dihydroxy-21-oxygenated-pregnadienes and processes of preparing the same
US3054812A (en) 20beta, 21-dinitrato-delta4-pregnene-17alpha-ol-3, 11-dione, its production, and method of use
FR1278267A (fr) Procédé de production d'acétate de butyle tertiaire
US3080391A (en) 6alpha-chloro-delta1, 4-androstadien-17beta-ol-3-one derivatives
BE778942A (fr) Procede de separation des constituants d'un melange de polyisocyanates organiques
GB1444154A (en) 15alpha, 16alpha-delta4-pregnenes
FR1270213A (fr) Procédé de préparation de composés d'alcanolamines solubles dans l'eau
GB1364034A (en) Terephthalonitrile purification process
CA959071A (en) Process for the separation and recovery of methylterephthalic acid and 4-methylisophthalic acid from a mixture thereof
FR1318518A (fr) Procédé de séparation d'un polymère amorphe d'une solution de ce polymère
FR1181755A (fr) Procédé de déshydrogénation de composés organiques et catalyseur pour ce procédé
FR1313002A (fr) Procédé de production d'isocyanates organiques
FR1169197A (fr) Procédé de séparation de mélanges de corps par partage répété
GB965571A (en) New steroid compounds and their formation
FR1244496A (fr) Procédé chimique de production de l'isoprène

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee